Free Webinar Recording 2016
“Fragment-based Drug Discovery: From inception to drug, the evolution of the tools that enabled Bcl-2 drug discovery and Venclexta approval”
Hosted by Vincent Stoll, Associate Director of Structural Biology, AbbVie
This webinar discusses the origins of Fragment-based drug discovery, driven by the need to discover drugs for the Bcl-2 protein. This was the first protein/protein interaction target to be tackled with a small molecule approach and traditional High throughput screening had failed to provide any viable starting points. A new approach was needed: fragment-based drug discovery.
It also covers the process and technologies of fragment-based drug Discovery and how they have evolved since the start of the Bcl-2 program. The science and technologies have evolved over time, expanding the approaches to fragment screening, significant advances in speed and quality of protein X-ray crystal structure information and integration of chemistry. This webinar gives an overview of what some of these advances are and how modern day fragment-based programs are organized and executed effectively.
Benefits to Downloading:
- Advance your knowledge on Fragmented-based Drug Discovery
- Hear about the latest the approaches to fragment screening
- Learn from a leading expert about his experience in Drug Discovery
- Hear about an innovative approach for Venclexta, a treatment of lymphocytic leukemia
Who Should Attend?
This webinar is for Drug Discovery researchers based in Europe and the US who would like to hear views from a leading expert on early-stage Drug Discovery strategies.
Terms & Conditions:
This webinar is exclusively for Drug Discovery professionals. If you are unsure whether you should attend, please contact for clarification. In very rare circumstances the event may be cancelled, postponed or the time changed. We will endeavour to contact you by telephone and email, it is therefore imperative that you provide the correct information. Failure to provide all the details we require on the registration form may result in your registration being cancelled.
By registering for this event you agree to be added to mailing list. If you would prefer not to receive emails about events and free webinars you can unsubscribe at any time.
Data Protection Act (1998)
Please note the personal information provided by you will be held on a database by Oxford Global in accordance with the Data Protection Act 1998. Data may be shared with the selected partners for the event that you are attending however we will not disclose personal data that you have provided to any other third party and the information you supply to us will only be used by Oxford Global and selected partners to contact you regarding training/events or our other services.